Understanding HER2 Low Breast Cancer

Understanding HER2 Low Breast Cancer

Update: 2025-04-29
Share

Description

- Overview of HER2 Low Breast Cancer
- What is the HER2 Status of My Cancer? What does this Mean?
- Diagnostic Testing: What is an Immunohistochemistry (IHC) Test or Fluorescence In Situ Hybridization (FISH) Test
- The Role of the Pathologist
- The Role of the Genetic Counselor
- Standard Treatment Options, Including Targeted Therapy
- How Biomarker Testing Informs Treatment Decisions
- New Targeted Treatments
- Updates on Investigational New Drugs in Clinical Trials
- How Research Contributes to Treatment Options
- What’s New in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort & Pain
- The Role of the Dietitian
- Guidelines to Prepare for Telemedicine/Telehealth Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes
- Key Questions to Ask Your Health Care Team About Quality-of-Life Concerns for HER2 Low Breast Cancer
- Questions for Our Panel of Experts
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Understanding HER2 Low Breast Cancer

Understanding HER2 Low Breast Cancer